Glucosa B. Braun (Glucose Monohydrate)

Glucosa B. Braun is indicated for several clinical situations where rapid provision of carbohydrate calories and fluid balance is required.

• Treatment of hypoglycemia when oral glucose is not feasible.
• Component of parenteral nutrition regimens for patients unable to receive enteral feeding.
• Fluid and electrolyte replacement in peri‑operative or critical‑care settings.
• Source of energy during surgery, trauma care, or prolonged fasting.
• Dilution medium for certain intravenous drug preparations when compatible.

When administered intravenously, Glucosa B. Braun may be associated with a range of adverse reactions, most of which are related to its osmolarity or glucose load.

Common

• Transient hyperglycemia, especially in patients with impaired glucose tolerance.
• Local irritation or pain at the infusion site.
• Mild electrolyte shifts such as mild hyponatremia.
• Nausea or vomiting if infused rapidly.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Fluid overload causing pulmonary edema in susceptible patients.
• Hypersensitivity reactions, including rash or anaphylaxis.
• Hyperosmolar hyperglycemic state in diabetic individuals.

Clinicians should observe specific precautions when prescribing Glucosa B. Braun to minimize risks and ensure appropriate therapeutic benefit.

• Verify blood glucose level before and during infusion to avoid excessive hyperglycemia.
• Assess fluid status and cardiac function to prevent volume overload.
• Adjust dose in patients with renal or hepatic impairment.
• Use caution in diabetic patients and those receiving insulin therapy.
• Monitor electrolytes, particularly sodium and potassium, during prolonged administration.
• Avoid rapid infusion rates that exceed recommended limits.

Glucosa B. Braun can interact with other medications or clinical conditions; awareness of these interactions helps maintain safety.

Avoid

• Concurrent administration with high‑dose insulin without glucose monitoring.
• Co‑infusion with potassium chloride solutions that may precipitate.
• Use with other hypertonic carbohydrate solutions that could exacerbate hyperglycemia.

Use with caution

• Simultaneous IV administration of diuretics, which may amplify fluid shifts.
• Concurrent use of corticosteroids that increase glucose production.
• Patients receiving total parenteral nutrition containing additional dextrose sources.